Original Research

Published on 15 Sep 2022

Clinical characteristics and prognosis of anti-γ-aminobutyric acid-B receptor encephalitis: A single-center, longitudinal study in China

in Multiple Sclerosis and Neuroimmunology

Xuedan Feng
Yujing Zhang
Yu Gao
Jing Zhang
Shasha Yu
Jing Lv
Yu Zu
Lin Wang
Xiangbo Wang

Frontiers in Neurology

doi 10.3389/fneur.2022.949843

2,269 views
6 citations

Case Report

Published on 15 Sep 2022

IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review

in Multiple Sclerosis and Neuroimmunology

Cheng Xia
Ping Li

Frontiers in Neurology

doi 10.3389/fneur.2022.986694

3,326 views
1 citation

Original Research

Published on 12 Sep 2022

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women

in Multiple Sclerosis and Neuroimmunology

Lin Han
Peiwei Hong
Yang Wan
Linjun Cai
Ziyan Shi
Jiancheng Wang
YanLin Lang
Hongyu Zhou

Frontiers in Neurology

doi 10.3389/fneur.2022.973163

1,694 views
3 citations

Original Research

Published on 08 Sep 2022

Early predictors of visual and axonal outcomes after acute optic neuritis

in Multiple Sclerosis and Neuroimmunology

Minh N. L. Nguyen
Chao Zhu
Scott C. Kolbe
Helmut Butzkueven
Owen B. White
Joanne Fielding
Trevor J. Kilpatrick
Gary F. Egan
Alexander Klistorner
Anneke van der Walt

Frontiers in Neurology

doi 10.3389/fneur.2022.945034

2,022 views
4 citations

Original Research

Published on 06 Sep 2022

The patient journey with NMOSD: From initial diagnosis to chronic condition

in Multiple Sclerosis and Neuroimmunology

Guillermo Delgado-Garcia
Sheryl Lapidus
Rosa Talero
Michael Levy

Frontiers in Neurology

doi 10.3389/fneur.2022.966428

8,543 views
8 citations

Opinion

Published on 01 Sep 2022

Time to rethink the reported disease-modifying treatment effects on cognitive outcomes: Methods and interpretative caveats

in Multiple Sclerosis and Neuroimmunology

Andrés Labiano-Fontcuberta
Enric Monreal
Julián Benito-León

Frontiers in Neurology

doi 10.3389/fneur.2022.995690

1,601 views
5 citations

Original Research

Published on 01 Sep 2022

Elevated ApoB/ApoA-I ratio is associated with acute anti-N-Methyl-D-aspartate receptor encephalitis, but not disease outcomes

in Multiple Sclerosis and Neuroimmunology

Yingying Liu
Xiaomeng Ma
Lili Ma
Zhumin Su
Donghong Li
Xiaohong Chen

Frontiers in Neurology

doi 10.3389/fneur.2022.896656

1,349 views
3 citations

Opinion

Published on 01 Sep 2022

Autoantibodies in post-treatment Lyme disease syndrome

in Multiple Sclerosis and Neuroimmunology

Armin Alaedini
Gary P. Wormser

Frontiers in Neurology

doi 10.3389/fneur.2022.1004853

1,786 views

Editorial

Published on 30 Aug 2022

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications

in Multiple Sclerosis and Neuroimmunology

Aurora Zanghì
Carlo Avolio
Hans-Peter Hartung
Emanuele D'Amico

Frontiers in Neurology

doi 10.3389/fneur.2022.996342

1,712 views
2 citations

Original Research

Published on 29 Aug 2022

Somatosensory evoked potentials and their relation to microstructural damage in patients with multiple sclerosis—A whole brain DTI study

in Multiple Sclerosis and Neuroimmunology

Jan Hamann
Barbara Ettrich
Karl Titus Hoffman
Florian Then Bergh
Donald Lobsien

Frontiers in Neurology

doi 10.3389/fneur.2022.890841

3,220 views

Case Report

Published on 29 Aug 2022

Anti-γ-aminobutyric acid-A receptor encephalitis with refractory seizures and cognitive impairment in a young woman: A case report

in Multiple Sclerosis and Neuroimmunology

Xue Yang
Bo Deng
Shengjun Wang
Xiaotang Wang
Lili Cao
Xiangjun Chen
Xiuhe Zhao

Frontiers in Neurology

doi 10.3389/fneur.2022.954494

2,223 views
2 citations

Original Research

Published on 29 Aug 2022

The use of functional near infrared spectroscopy and gait analysis to characterize cognitive and motor processing in early-stage patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Maria Adelia de Aratanha
Joana Bisol Balardin
Carolina Cardoso do Amaral
Shirley S. Lacerda
Tiago Abrão Setrak Sowmy
Theodore J. Huppert
Rodrigo Barbosa Thomaz
Danielli S. Speciali
Birajara Machado
Elisa Harumi Kozasa

Frontiers in Neurology

doi 10.3389/fneur.2022.937231

2,826 views
5 citations

Case Report

Published on 29 Aug 2022

Atypical acute disseminated encephalomyelitis with systemic inflammation after a first dose of AztraZaneca COVID-19 vaccine. A case report

in Multiple Sclerosis and Neuroimmunology

Laure Bastide
Gaetano Perrotta
Valentina Lolli
Céline Mathey
Ortensa-Irina Vierasu
Serge Goldman
Frédéric Vandergheynst

Frontiers in Neurology

doi 10.3389/fneur.2022.995875

5,341 views
5 citations

Editorial

Published on 26 Aug 2022

Editorial: Advances in neuromyelitis optica spectrum disorders

in Multiple Sclerosis and Neuroimmunology

Yu Cai
Jodie M. Burton
Fu-Dong Shi
Wei Qiu
Yangtai Guan

Frontiers in Neurology

doi 10.3389/fneur.2022.1005164

2,023 views

Original Research

Published on 25 Aug 2022

Comparative analysis of clinical and imaging data of first-attack neuromyelitis optica spectrum disorders with and without connective tissue disease

in Multiple Sclerosis and Neuroimmunology

Yaobing Yao
Xuan Yang
Yongyan Zhou
Haojie Xie
Ranran Duan
Lijun Jing
Yanfei Li
Wenjuan Guan
Junfang Teng
Yanjie Jia

Frontiers in Neurology

doi 10.3389/fneur.2022.969762

2,009 views
7 citations

Editorial

Published on 22 Aug 2022

Editorial: Disease modifying therapies in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Simona Bonavita
Mahsa Ghajarzadeh
Luigi Lavorgna

Frontiers in Neurology

doi 10.3389/fneur.2022.927321

1,879 views

Navigation group

Articles

Clinical characteristics and prognosis of anti-γ-aminobutyric acid-B receptor encephalitis: A single-center, longitudinal study in China

IgG4-related hypertrophic pachymeningitis with ANCA-positivity: A case series report and literature review

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women

Early predictors of visual and axonal outcomes after acute optic neuritis

The patient journey with NMOSD: From initial diagnosis to chronic condition

Time to rethink the reported disease-modifying treatment effects on cognitive outcomes: Methods and interpretative caveats

Elevated ApoB/ApoA-I ratio is associated with acute anti-N-Methyl-D-aspartate receptor encephalitis, but not disease outcomes

Autoantibodies in post-treatment Lyme disease syndrome

Editorial: Immunosenescence and multiple sclerosis: Prognostic and therapeutic implications

Somatosensory evoked potentials and their relation to microstructural damage in patients with multiple sclerosis—A whole brain DTI study

Anti-γ-aminobutyric acid-A receptor encephalitis with refractory seizures and cognitive impairment in a young woman: A case report

The use of functional near infrared spectroscopy and gait analysis to characterize cognitive and motor processing in early-stage patients with multiple sclerosis

Atypical acute disseminated encephalomyelitis with systemic inflammation after a first dose of AztraZaneca COVID-19 vaccine. A case report

Editorial: Advances in neuromyelitis optica spectrum disorders

Comparative analysis of clinical and imaging data of first-attack neuromyelitis optica spectrum disorders with and without connective tissue disease

Editorial: Disease modifying therapies in multiple sclerosis